Heartland Advisors, Inc.
+5.63%
3M Return
$36.820
-0.070 (-0.19%)收盤時
Chiron Real Estate Inc., formerly Global Medical REIT Inc., is an internally managed real estate investment trust (REIT). The Company acquires healthcare facilities leased to physician groups and regional and national healthcare systems. The Company conducts its business through its limited partnership subsidiary, Chiron Real Estate LP (operating partnership). It owns 92.0% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 8.0% of the operating partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. Its portfolio is located in various areas, including Texas, Florida, Ohio, Arizona, Pennsylvania, Illinois, and Others.
Chiron Real Estate Inc is currently a hold. The stock's current price is $36.82, which is below the analyst price target range of $40 to $43, indicating potential upside. However, the RSI is at 47.423, suggesting that the stock is neither overbought nor oversold, and the forward P/E ratio is 44.44, indicating high valuation concerns. The recent Q2 earnings showed a strong FFO of $0.88, beating expectations, but the company's transition strategy may dilute earnings in the short term. The main risk is the high forward P/E ratio, which may lead to volatility if earnings do not meet expectations.

Chiron Real Estate Q2 Earnings Beat Expectations

Analysis of XRN Dividend Expectations and Performance

Chiron Real Estate Appoints New Executives

Chiron Real Estate Dividend History Analysis

Chiron Real Estate Sells Seven Rehabilitation Facilities
Chiron Real Estate Inc., formerly Global Medical REIT Inc., is an internally managed real estate investment trust (REIT). The Company acquires healthcare facilities leased to physician groups and regional and national healthcare systems. The Company conducts its business through its limited partnership subsidiary, Chiron Real Estate LP (operating partnership). It owns 92.0% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 8.0% of the operating partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. Its portfolio is located in various areas, including Texas, Florida, Ohio, Arizona, Pennsylvania, Illinois, and Others. It operates in the Real Estate sector.
Chiron Real Estate Inc is currently a hold. The stock's current price is $36.82, which is below the analyst price target range of $40 to $43, indicating potential upside. However, the RSI is at 47.423, suggesting that the stock is neither overbought nor oversold, and the forward P/E ratio is 44.44, indicating high valuation concerns. The recent Q2 earnings showed a strong FFO of $0.88, beating expectations, but the company's transition strategy may dilute earnings in the short term. The main risk is the high forward P/E ratio, which may lead to volatility if earnings do not meet expectations.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。